Pancreatic cancer is the fourth most common cause of cancer deaths in Germany. With a five-year survival rate of only 6%, pancreatic cancer is one of the most aggressive malignancies in Europe. Despite advances in the standardisation and development of cancer treatment, surgical removal of the tumour with the aim of cure is only possible in 20 % of patients, as the disease is often only diagnosed at an advanced stage. In such cases, chemotherapy remains the only palliative treatment option.